News Chart Akeso, Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 01:38:35 18/07/2025 pm IST			5-day change	1st Jan Change
140.70 ^HKD	+0.86%		+29.92%	+131.80%

02:12pm	Nomura Adjusts Akeso's Price Target to HK$120.64 From HK$99.66, Keeps at Neutral	MT
16/07	Akeso, Inc. Announces First Patient Enrolled in the Phase III Trial (AK112-312/HARMONi-GI6) of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer	CI

2ad9a7a0.hwTzJWpM4ja2HuC_K6mK1NpryR5vWPnRcbtNNglkbGE.8U-CcykBkELYRLmGW8jCmbkBvWk4Er-BJIoPBnA1BSv0MJlRCya4BZtc2A~2a5e790920420cc718edb33ca928a62a